Next 10 |
When the markets were roaring upwards in 2020 and investment capital was abundant, the number of Special Purpose Acquisition Companies (SPACs) going public broke records. Competition to find ideal companies to merge with to fulfill the SPAC’s mission, intensified. Almost two years have ...
Proceeds from this transaction will be used to further support the national launch of Plenity Gelesis will begin trading on the New York Stock Exchange as “GLS” on Friday, January 14, 2022 and will ring the opening bell on Tuesday, January 18 Gelesis, t...
Ms. Bauerlein brings success in scaling to $300M+ revenue in direct-to-consumer business model and public company execution as Gelesis plans to scale Plenity® to meet growing consumer demand with its upcoming NYSE listing Bauerlein joins Gelesis’ board of industry ...
With the prevalence of fad diets, food shaming and resulting guilt, leading health experts advise against villainizing specific food groups and moving to flexibility and moderation One-of-a-kind, multisensory activation from Plenity® highlights this shifting conversation,...
Plenity® is transforming weight management with a clinically proven approach made from naturally derived building blocks As Chief Nutrition Officer, Bauer will focus on educating healthcare professionals and offering nutrition counseling to Plenity members Geles...
Recorded November 11, 2021. Noble Capital Markets Senior Research Analyst Gregory Aurand interviews Gelesis Founder and CEO Yishai Zohar, Chief Operating and Commercial Officer David Pass and CFO Elliot Maltz to discuss the planned SPAC merger with Capstar Special Purpose Acquisition Corp. Re...
Gelesis’ new commercial manufacturing facility is now producing Plenity® at large scale, enabling supply to meet the growing demand Gelesis announced today that leading U.S. direct-to-patient healthcare company Ro has placed a $30 million fully paid pre-order for...
Updated acquisition terms. Gelesis, Inc. will be brought public when they merge with publicly traded Capstar Special Acquisition Corp. (CPSR). The combination value was revised at the agreement of both companies. See Stock Overview and Valuation section in this report for updated details. The ...
New paper describes the first superabsorbent hydrogel technology made from naturally derived building blocks designed to address obesity and gut related conditions by emulating compositional and mechanical properties of raw vegetables The newly published data showed that speci...
Chief Scientific Officer Elaine Chiquette, Pharm.D., Named Among the Top 25 Women Leaders in Biotechnology Elizabeth Pash, MS, RD, LDN, Honored by Academy of Nutrition and Dietetics for Excellence in Practice Gelesis, a consumer-focused biotherapeutics company and th...
News, Short Squeeze, Breakout and More Instantly...
Capstar Special Purpose Company Name:
CPSR Stock Symbol:
NYSE Market:
Capstar Special Purpose Website:
When the markets were roaring upwards in 2020 and investment capital was abundant, the number of Special Purpose Acquisition Companies (SPACs) going public broke records. Competition to find ideal companies to merge with to fulfill the SPAC’s mission, intensified. Almost two years have ...
Proceeds from this transaction will be used to further support the national launch of Plenity Gelesis will begin trading on the New York Stock Exchange as “GLS” on Friday, January 14, 2022 and will ring the opening bell on Tuesday, January 18 Gelesis, t...
Ms. Bauerlein brings success in scaling to $300M+ revenue in direct-to-consumer business model and public company execution as Gelesis plans to scale Plenity® to meet growing consumer demand with its upcoming NYSE listing Bauerlein joins Gelesis’ board of industry ...